Teladoc Health, Inc. (NYSE:TDOC) Receives $7.54 Average Price Target from Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned an average rating of “Hold” from the sixteen analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $7.5357.

A number of brokerages have issued reports on TDOC. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Canaccord Genuity Group lowered their price objective on Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. Bank of America lifted their target price on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Finally, Citigroup lowered their price target on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a report on Monday, August 3rd.

Teladoc Health Price Performance

NYSE:TDOC opened at $6.26 on Friday. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of -6.32 and a beta of 2.12. The firm’s fifty day moving average price is $7.16 and its 200 day moving average price is $6.82. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.89.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The business had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same period in the previous year, the business posted ($0.19) earnings per share. The business’s revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, analysts expect that Teladoc Health will post -0.92 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Charles III sold 17,805 shares of the business’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the transaction, the chief executive officer owned 465,535 shares in the company, valued at approximately $2,839,763.50. The trade was a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company’s stock.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently modified their holdings of the business. Versant Capital Management Inc boosted its position in shares of Teladoc Health by 33.3% in the 2nd quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock valued at $70,000 after purchasing an additional 2,052 shares during the period. ProShare Advisors LLC increased its holdings in shares of Teladoc Health by 8.2% during the 4th quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider’s stock valued at $228,000 after acquiring an additional 2,457 shares during the last quarter. HighTower Advisors LLC raised its holdings in Teladoc Health by 20.8% in the 2nd quarter. HighTower Advisors LLC now owns 16,808 shares of the health services provider’s stock worth $143,000 after acquiring an additional 2,893 shares during the period. Allworth Financial LP acquired a new position in Teladoc Health during the 2nd quarter worth $25,000. Finally, Twin Lakes Capital Management LLC bought a new stake in Teladoc Health during the second quarter valued at about $26,000. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company’s offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.